Upregulation of rack-1 in melanoma and its use as a marker
Dec 09, 2015
Institut Pasteur, Ecole Nationale Veterinaire D’Alfort, Institut Curie, Centre National de la Recherche Scientifique, and Institut National de la Recherche Agronomique have been awarded US Patent No. 9,201,076, "Upregulation of rack-1 in melanoma and its use as a marker."
While next-generation sequencing (NGS) has driven recent advances in precision oncology research, it often falls short when identifying the molecular mechanisms underlying many malignancies. As a result, alternative NGS-based approaches are needed to identify oncogenic drivers and potential drug targets.